Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant

• Register: ClinicalTrials.gov
• Last refreshed on: 17 October 2012
• Main ID: NCT00305851
• Date of registration: 21/03/2006
• Primary sponsor: Children's Oncology Group
• Public title: Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant
• Scientific title: Music Video and Adolescent/Young Adult Resilience During Transplant
• Date of first enrolment: April 2006
• Target sample size: 130
• Recruitment status: Completed
• URL: http://clinicaltrials.gov/show/NCT00305851
• Study type: Interventional
• Study design: Allocation: Randomized

Countries of recruitment

United States

Contacts

• Name: Joan E. Haase, PhD, RN
• Affiliation: Indiana University Melvin and Bren Simon Cancer Center

• Name: Sheri L. Robb, PhD
• Affiliation: University of Missouri, Kansas City

Key inclusion & exclusion criteria

DISEASE CHARACTERISTICS:

- Diagnosis of an oncology condition requiring allogeneic or autologous transplantation

- Receiving or planning to receive a myeloablative treatment regimen and 1 of the
following:

- Marrow transplantation

- Peripheral stem cell transplantation

- Cord blood stem cell transplantation

- Patients with cancers that do not usually occur in childhood/adolescent or young
adult populations (e.g., breast or prostate cancer) are not eligible

PATIENT CHARACTERISTICS:

- Able to read and speak English

- English does not need to be the primary language

- Able to participate in the sessions as evaluated for alertness and engagement by the
music therapist

- No cognitive impairments that would make it difficult to participate in the
intervention or complete questionnaires

- Not married and not a parent

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics

- Concurrent therapy for pain control or relief of other symptoms allowed



Age minimum: 11 Years
Age maximum: 24 Years
Gender: Both

Health Condition(s) or Problem(s) studied

Cancer

Intervention(s)

Procedure: music therapy

Procedure: psychosocial assessment and care

Procedure: quality-of-life assessment

Primary Outcome(s)

Symptoms-related distress (pain, anxiety, fatigue, mucositis, sedation, and mood) at pre- and post-sessions 2, 4, and 6, baseline, immediately after completion of study treatment, and 100 days post-transplant [Time Frame: No]

Uncertainty in illness as assessed by the Mishel Uncertainty in Illness Scale at baseline, immediately after completion of study treatment, and 100 days post-transplant [Time Frame: No]

Use of defensive coping as assessed immediately after completion of study treatment, and 100 days post-transplant [Time Frame: No]

Use of positive coping as assessed immediately after completion of study treatment, and 100 days post-transplant [Time Frame: No]

Secondary Outcome(s)

Adaptability or cohesion as assessed by FACES II at baseline, immediately after completion of study treatment, and 100 days post-transplant [Time Frame: No]

Communication with family as assessed by Parent-Adolescent Communication at baseline, immediately after completion of study treatment, and 100 days post-transplant [Time Frame: No]

Greater derived meaning from stem cell transplantation (STC) experience immediately after completion of study treatment, and 100 days post-transplant [Time Frame: No]

Higher resilience immediately after completion of study treatment, and 100 days post-transplant [Time Frame: No]

Perceived social support from friends, family, and healthcare providers at baseline, immediately after completion of study treatment, and 100 days post-transplant [Time Frame: No]

Quality of life at baseline, immediately after completion of study treatment, and 100 days post-transplant [Time Frame: No]

Secondary ID(s)

CDR0000463879

COG-ANUR0631

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

National Cancer Institute (NCI)

National Institute of Nursing Research (NINR)